3FERRARI S, SMELAND S, MERCURI M, et al. Neoadjuvant chem- otherapy with high -dose Ifosfamide, high -dose methotrexate, cispl- atin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups[J]. J Clin Oncol, 2005, 23(34) : 8845 -8852.
5MEYERS P A, SCHWARTZ C L, KRAILO M D, et al. Osteosar- coma: the addition of muramyl - tripeptide to chemotherapy im- prove sover all survival: a report from the Children's Oncology Group[J]. J Clin Oncol, 2008, 26(4): 633 -638.
6LONGHI A, FERRARI S, BACCI G, et al. Long - term follow - up of patients with doxorubicin - induced cardiac toxicity after chemotherapy for osteosarcoma [ J ]. Anticancer Drugs, 2007, 18 ( 6 ) : 737 - 744.
7BASARAN M, BAVBEK E S, SAGLAM S, et al. A phase II study of eisplatin, if osfamide and epirubiein combination chemo- therapy in adults with non metastatic and extremity osteosarcomas [J]. Oncology, 2007, 72(3/4): 255 -260.
9JAFFE N, GORLICK R. High - dose methotrexate in osteosarco- ma : let the questions surcease time for final acceptance [ J ]. J Clin Oncol, 2008, 26 (27) : 4365 - 4366.
10Woodward JK, Neville - webbe HL, Coleman RE, et al. Combined effects of zoledronic acid and doxorubicin on breast cancer cell invasion in vitro[ J ]. Anticancer Drugs, 2005,16:845 - 854.
4Clucas J, Valderrama F. ERM proteins in cancer progression [ J ]. J Cell Sci, 2014, 127(Pt2) : 267 -275.
5Donald G, Hertzer K, Eibl G. Baicalein-an intriguing therapeutic phytochemical in pancreatic cancer [ J ]. Curr Drug Targets, 2012, 13(14) : 1772-1776.
6Naveenkumar C, Raghunandhakumar S, Asokkumar S, et al. Baicalein abrogates reactive caygen species (ROS)-rrediated n4tochondrial dysfunctima during experimental pulmonary carcinogenesis in vivo[ J]. Basic Clin Pharmacol Toxicol, 2013, 112(4) : 270-281.
7Chen K, Zhang S, Ji Y, et al. Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathway [ J/OA. PLoS One, 2013, 8 (9) : e72927.
8Zhang Y, Zhang L, Zhang G, et al. Ost metastasis: prospective role of ezfin[J]. Tumour Biol, 2014, 35(6) : 5055 -5059.
9Adada M, Canals D, Hannun YA, et al. Sphingolipid regulation of ezrin, radixin, and moesin proteins family: implications for cell dynamics [ J ]. Biochim Biophys Acta, 2014, 1841 (5) : 727 - 737.
10Parnell E, Yarwood SJ. Interactions between Epacl and ezrin in the control of endothelial barrier function [ J ]. Biochem Soc Trans, 2014, 42(2) : 274 -278.
